These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 19208092

  • 1. Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells.
    Bairey O, Vanichkin A, Shpilberg O.
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e77-85. PubMed ID: 19208092
    [Abstract] [Full Text] [Related]

  • 2. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
    Scamardella F, Maconi M, Albertazzi L, Gamberi B, Gugliotta L, Brini M.
    Lab Hematol; 2006 Feb; 12(4):187-92. PubMed ID: 17118768
    [Abstract] [Full Text] [Related]

  • 3. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells.
    Santini V, Gozzini A, Scappini B, Caporale R, Zoccolante A, Rigacci L, Gelardi E, Grossi A, Alterini R, Ferrini PR.
    Haematologica; 1999 Oct; 84(10):897-904. PubMed ID: 10509037
    [Abstract] [Full Text] [Related]

  • 4. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
    Hu XM, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
    [Abstract] [Full Text] [Related]

  • 5. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
    Giri U, Terry NH, Kala SV, Lieberman MW, Story MD.
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
    [Abstract] [Full Text] [Related]

  • 6. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid.
    Li JJ, Tang Q, Li Y, Hu BR, Ming ZY, Fu Q, Qian JQ, Xiang JZ.
    Acta Pharmacol Sin; 2006 Aug; 27(8):1078-84. PubMed ID: 16867262
    [Abstract] [Full Text] [Related]

  • 7. Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells.
    Hu XM, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2003 Feb; 51(2):119-26. PubMed ID: 12647012
    [Abstract] [Full Text] [Related]

  • 8. Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia.
    Goolsby C, Paniagua M, Tallman M, Gartenhaus RB.
    Cytometry B Clin Cytom; 2005 Jan; 63(1):36-46. PubMed ID: 15624202
    [Abstract] [Full Text] [Related]

  • 9. In vitro arsenic trioxide induces apoptosis in T cells of asthmatic patients by a Bcl-2 related mechanism.
    Qin DY, Huang R, Wu T.
    Yao Xue Xue Bao; 2008 Jan; 43(1):35-43. PubMed ID: 18357729
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D, Tazzari PL, Capaia M, Montera MP, Clavio M, Balleari E, Foa R, Gobbi M.
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [Abstract] [Full Text] [Related]

  • 12. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
    Campàs C, Cosialls AM, Barragán M, Iglesias-Serret D, Santidrián AF, Coll-Mulet L, de Frias M, Domingo A, Pons G, Gil J.
    Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
    Thomas A, El Rouby S, Reed JC, Krajewski S, Silber R, Potmesil M, Newcomb EW.
    Oncogene; 1996 Mar 07; 12(5):1055-62. PubMed ID: 8649796
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
    Buske C, Gogowski G, Schreiber K, Rave-Fränk M, Hiddemann W, Wörmann B.
    Exp Hematol; 1997 Apr 07; 25(4):329-37. PubMed ID: 9131008
    [Abstract] [Full Text] [Related]

  • 16. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA.
    Cheng B, Yang X, Han Z, An L, Liu S.
    Auris Nasus Larynx; 2008 Mar 07; 35(1):95-101. PubMed ID: 17869043
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3.
    Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y, Kondo S.
    Oncogene; 2005 Feb 03; 24(6):980-91. PubMed ID: 15592527
    [Abstract] [Full Text] [Related]

  • 19. The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells.
    de Vries JF, Falkenburg JH, Willemze R, Barge RM.
    Haematologica; 2006 Jul 03; 91(7):912-9. PubMed ID: 16818278
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells.
    Chow SK, Chan JY, Fung KP.
    J Cell Biochem; 2004 Sep 01; 93(1):173-87. PubMed ID: 15352174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.